Phathom Pharmaceuticals Inc (PHAT)
10.42
-0.27
(-2.53%)
USD |
NASDAQ |
May 17, 14:41
Phathom Pharmaceuticals Debt to Equity Ratio: -1.004 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | -1.004 |
Date | Value |
---|---|
December 31, 2023 | -1.894 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.894
Minimum
Dec 2023
-1.004
Maximum
Mar 2024
-1.449
Average
-1.449
Median
Debt to Equity Ratio Benchmarks
Regeneron Pharmaceuticals Inc | 0.0735 |
Ocular Therapeutix Inc | 0.1629 |
Rhythm Pharmaceuticals Inc | 0.00 |
Xeris Biopharma Holdings Inc | -25.02 |
Gritstone Bio Inc | 2.888 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 356.50M |
Total Liabilities (Quarterly) | 505.00M |
Shareholders Equity (Quarterly) | -148.50M |
Current Ratio | 7.831 |